Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Sirolimus in pediatric renal transplantation.

Kasap B.

Pediatr Transplant. 2011 Nov;15(7):673-85. doi: 10.1111/j.1399-3046.2011.01575.x. Review.

PMID:
22004542
[PubMed - indexed for MEDLINE]
2.

Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation.

Hymes LC, Warshaw BL.

Pediatr Transplant. 2011 Jun;15(4):437-41. doi: 10.1111/j.1399-3046.2011.01477.x. Epub 2011 Feb 21.

PMID:
21338459
[PubMed - indexed for MEDLINE]
3.

Sirolimus in solid organ transplantation: current therapies and new frontiers.

Veroux M, Tallarita T, Corona D, D'Assoro A, Gurrieri C, Veroux P.

Immunotherapy. 2011 Dec;3(12):1487-97. doi: 10.2217/imt.11.143.

PMID:
22091684
[PubMed - indexed for MEDLINE]
4.

Use of sirolimus in solid organ transplantation.

Augustine JJ, Bodziak KA, Hricik DE.

Drugs. 2007;67(3):369-91. Review.

PMID:
17335296
[PubMed - indexed for MEDLINE]
5.

Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.

Ettenger RB, Grimm EM.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 2):S22-8. Review.

PMID:
11583941
[PubMed - indexed for MEDLINE]
6.

Conversion to sirolimus in pediatric renal transplantation recipients.

Garcia CD, Bittencourt VB, Alves AB, Garcia VD, Tumelero A, Antonello JS, Malheiros D.

Transplant Proc. 2006 Jul-Aug;38(6):1901-3.

PMID:
16908317
[PubMed - indexed for MEDLINE]
7.

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.

Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF; Sirolimus High-Risk Study Group.

Transplantation. 2008 Nov 15;86(9):1187-95. doi: 10.1097/TP.0b013e318187bab0.

PMID:
19005398
[PubMed - indexed for MEDLINE]
8.

Clinical insights for cancer outcomes in renal transplant patients.

Alberú J.

Transplant Proc. 2010 Nov;42(9 Suppl):S36-40. doi: 10.1016/j.transproceed.2010.07.006. Review.

PMID:
21095450
[PubMed - indexed for MEDLINE]
9.

Early sirolimus therapy in renal transplant recipients at high risk: is it justified?

Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR.

Transplant Proc. 2009 Sep;41(7):2784-8. doi: 10.1016/j.transproceed.2009.07.015.

PMID:
19765435
[PubMed - indexed for MEDLINE]
10.

Sirolimus in chronic allograft nephropathy in pediatric recipients.

Ibáñez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF.

Pediatr Transplant. 2007 Nov;11(7):777-80.

PMID:
17910656
[PubMed - indexed for MEDLINE]
11.

The role and value of sirolimus administration in kidney and liver transplantation.

Mehrabi A, Fonouni H, Kashfi A, Schmied BM, Morath Ch, Sadeghi M, Schemmer P, Encke J, Sauer P, Zeier M, Weitz J, Büchler MW, Schmidt J.

Clin Transplant. 2006;20 Suppl 17:30-43. Review.

PMID:
17100699
[PubMed - indexed for MEDLINE]
12.

Sirolimus for calcineurin inhibitors in organ transplantation: contra.

Cravedi P, Ruggenenti P, Remuzzi G.

Kidney Int. 2010 Dec;78(11):1068-74. doi: 10.1038/ki.2010.268. Epub 2010 Aug 11. Review.

PMID:
20703217
[PubMed - indexed for MEDLINE]
13.

Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.

Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.

Clin Transplant. 2004;18 Suppl 12:61-6.

PMID:
15217410
[PubMed - indexed for MEDLINE]
14.

[Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].

Roque E J, Ríos M G, Vignolo A P, Pinochet V C, Schultz M, Humeres A R, Delucchi A, Rius A M, Hepp K J.

Rev Med Chil. 2008 May;136(5):631-6. doi: /S0034-98872008000500013. Epub 2008 Jul 30. Spanish.

PMID:
18769812
[PubMed - indexed for MEDLINE]
Free Article
15.

Conversion to sirolimus in posttransplant renal neoplasms.

Lopez V, Gutierrez C, Cabello M, Burgos D, Sola E, Gonzalez-Molina M.

Transplant Proc. 2007 Sep;39(7):2264-6.

PMID:
17889158
[PubMed - indexed for MEDLINE]
16.

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.

Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP; Sirolimus Renal Function Study Group.

Transplantation. 2002 Dec 15;74(11):1560-7.

PMID:
12490789
[PubMed - indexed for MEDLINE]
17.

Sirolimus in pediatric renal transplantation.

Ibáñez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A.

Transplant Proc. 2005 Mar;37(2):682-4.

PMID:
15848500
[PubMed - indexed for MEDLINE]
18.

Management of side effects of sirolimus therapy.

Stallone G, Infante B, Grandaliano G, Gesualdo L.

Transplantation. 2009 Apr 27;87(8 Suppl):S23-6. doi: 10.1097/TP.0b013e3181a05b7a.

PMID:
19384183
[PubMed - indexed for MEDLINE]
19.

Benefit-risk assessment of sirolimus in renal transplantation.

Kuypers DR.

Drug Saf. 2005;28(2):153-81. Review.

PMID:
15691225
[PubMed - indexed for MEDLINE]
20.

Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.

Jiménez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL.

Pediatr Transplant. 2004 Jun;8(3):243-8.

PMID:
15176961
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk